Amicus Therapeutics Inc. buy Morgan Stanley
Start price
10.05.24
/
50%
€8.60
Target price
10.05.25
€17.64
Performance (%)
12.21%
Price
03.10.24
€9.45
Summary
This prediction is currently active. The prediction currently has a performance of 12.21%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -0.526% | -0.526% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Morgan Stanley from $20.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
19.12.23
19.12.23
€18.24
19.12.24
19.12.24
-19.58%
03.10.24
03.10.24